• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

    31.00 +0.86 (+2.85%)
    Streaming Delayed Price Updated: 9:42 AM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 412,583
    Open 31.47
    Bid (Size) 30.79 (100)
    Ask (Size) 31.00 (200)
    Prev. Close 30.14
    Today's Range 30.78 - 31.50
    52wk Range 4.600 - 34.39
    Shares Outstanding 88,406,523
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Tango Therapeutics Appoints Robert Azelby to Board of Directors
    From Tango Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
    From Tango Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +247.1%
    +247.1%
    1 Month
    +54.7%
    +54.7%
    3 Month
    +56.1%
    +56.1%
    6 Month
    +257.6%
    +257.6%
    1 Year
    +523.7%
    +523.7%

    More News

    Read More
    News headline image
    Tango Therapeutics Announces Proposed $500 Million Public Offering
    From Tango Therapeutics, Inc.
    Via GlobeNewswire
    These stocks are moving in today's session ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer
    From Tango Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Tango Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More ↗
    Via The Motley Fool
    News headline image
    Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 ↗
    Via The Motley Fool
    Topics Regulatory Compliance Stocks
    News headline image
    Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗
    Via The Motley Fool
    News headline image
    Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
    From Tango Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Tango Therapeutics Sub, Inc
    Via GlobeNewswire
    News headline image
    Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
    From Tango Therapeutics Sub, Inc
    Via GlobeNewswire
    News headline image
    Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗
    Via The Motley Fool
    News headline image
    Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Tango Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Tango Therapeutics, Inc. - Common Stock trade on?
    Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?
    The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market
    What is the current price of Tango Therapeutics, Inc. - Common Stock?
    The current price of Tango Therapeutics, Inc. - Common Stock is 31.00
    When was Tango Therapeutics, Inc. - Common Stock last traded?
    The last trade of Tango Therapeutics, Inc. - Common Stock was at 06/26/26 09:42 AM ET
    What is the market capitalization of Tango Therapeutics, Inc. - Common Stock?
    The market capitalization of Tango Therapeutics, Inc. - Common Stock is 2.74B
    How many shares of Tango Therapeutics, Inc. - Common Stock are outstanding?
    Tango Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.